Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology.
Rasio Therapeutics has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in November 2021.
Rasio Therapeutics's investors include National Foundation for Cancer Research.
Rasio Therapeutics is headquartered in Baltimore, United States.
Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology.
Rasio Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rasio Therapeutics — Funding & Investors." VCBacked, November 26, 2021, https://www.vcbacked.co/company/rasio-therapeutics. Accessed August 14, 2026.
VCBacked. (2021). Rasio Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rasio-therapeutics
{{cite web |title=Rasio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rasio-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated